Business Wire

PENTAX Medical Launches OPTIVISTA-EPK-i7010 Video Processor

Del

PENTAX Medical launches a world first, the OPTIVISTA EPK-i7010 Video Processor, featuring both digital and optical enhancements, in the European, Middle Eastern & African (EMEA) markets. This unique enhancement combination provides detailed information for more accurate in vivo diagnosis through improved vessel and mucosal pattern characterization.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160510005811/en/

The new OPTIVISTA EPK-i7010 video processor uniquely features both digital and optical enhancements  ...

The new OPTIVISTA EPK-i7010 video processor uniquely features both digital and optical enhancements for more accurate in vivo diagnosis. For a high resolution image, please contact sarahp@alto-marketing.com (Photo: Business Wire)

The introduction of OPTIVISTA offers physicians both digital (i-scan Surface and Tone Enhancements) and Optical Enhancement (i-scan OE), with the new optical filter producing bandwidth-limiting light. When combined with image enhancement processing technology i-scan OE clearly displays the surface structures of blood vessels, glandular ducts and mucosal membrane in higher contrasts than white light. This unique combination with the proven digital i-scan technology, in one video processor, provides an enhanced view of the mucosal structures and vascular patterns, supporting early detection, demarcation and characterization. Physicians can switch seamlessly in real time amongst HD+ white light and three i-scan modes which includes i-scan OE to view multiple aspects of tissue structure.

PENTAX Medical’s new OPTIVISTA EPK-i7010 video processor, together with its latest i10 HD+ endoscopes series, or with its MagniView, optical zoom endoscopes, provides market leading image quality. Perfectly suited to routine procedures or complex interventions, the OPTIVISTA is designed to support the optimal clinical outcome.

Dr Silvia Sanduleanu, Maastricht UMC+, The Netherlands, who has been involved in early studies with OPTIVISTA said, “Contrast enhancement using i-scan OE highlights the epithelial mucosal surface pattern and especially the vascular pattern in detail. i-scan OE facilitates detection and in vivo diagnosis of lower gastrointestinal tract pathology enabling targeted endotherapy.”

In addition to improved diagnosis, OPTIVISTA is a powerful teaching platform. TwinMode is useful in teaching the appropriate interpretation of image enhanced endoscopy, providing simultaneous comparison of side by side endoscopic images. The simultaneous comparison of enhanced clinical images is particularly useful in demonstrating the appropriate characterization of lesions.

Also included with the OPTIVISTA is the ability to perform video recording, enabling the capture of HD+ video files onto a USB storage device. Audio recording for video is captured through an external microphone. The new, intuitive touch screen controls allow for simple and efficient operation. For optimum image collection, the OPTIVISTA incorporates freeze scan technology which automatically selects the sharpest picture for users’ records. By integrating the video and audio capture functionality there is no requirement for further recording devices or software.

Rainer Burkard, President EMEA of PENTAX Medical commented: “This is just one of a series of exciting product launches for PENTAX Medical this year. We are looking to increase our support to consultants across GI, ENT and bronchoscopy by adding to our product portfolio over the coming months. This is a proud moment for us as a business, OPTIVISTA will have a marked effect on the diagnosis possibilities for consultants. Working with our other technologies we are in a strong position to support the entire clinical pathway, from initial identification through to therapy.”

About PENTAX Medical

PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. For more information, please visit: www.pentaxmedical.com.

Contact information

PENTAX Europe GmbH
Sangeeta Gehlot-Vadher
EMEA PR Manager
T: +44 (0)1753 792 733
F: +44 (0)1753 792 794
E: sangeeta.gehlot@pentaxmedical.com
W: www.pentaxmedical.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Edgewater Networks Announces Event Sponsorship of BroadSoft Connections 201720.10.2017 21:00Pressemelding

Edgewater Networks, Inc., the industry leader in Network Edge Orchestration, announced today that it is an event sponsor of the BroadSoft Connections 2017 user conference, which takes place October 22-25 at the JW Marriott Phoenix Desert Ridge Resort & Spa in Phoenix, AZ. During the event, Edgewater Networks will feature demonstrations of the latest end-to-end network interoperability capabilities, including Zero Touch Provisioning, UC Analytics from the core to the endpoint, SD-WAN optimized for BroadSoft, and much more. Continuing a long-standing partnership with BroadSoft, Edgewater Networks has completed another level of BroadCloud certification, this time for local survivability which is critical for business continuity for SMB and Enterprise customers. BroadSoft’s PacketSmart is available on all EdgeMarc Intelligent Edges. All elements of the Network Edge Orchestration are

More than 70 Companies to Showcase Top Tech at CES Unveiled Paris20.10.2017 15:08Pressemelding

The Consumer Technology Association (CTA) today announced that more than 70 exhibitors will showcase their latest innovations at the now sold-out fifth annual CES Unveiled Paris The event will focus on the Internet of Things (IoT), connectivity and smart cities, and draw more than 600 attendees. CES Unveiled Paris will run from 2-7:30 PM on Tuesday, October 24, 2017 at the Palais Brongniart. Regional technology companies, top-tier media outlets, buyers and key industry influencers will come together at CES Unveiled Paris to get a direct look at the latest industry developments. The day kicks off with a CES news conference and CTA market trends presentation. Conference programming is followed by a tabletop exhibition & networking reception. Curated exhibitors will be there to showcase top tech from robotics and audio to smart home and augmented and virtual reality. Notable

Westinghouse Receives Regulatory Approval for Analysis Methodologies20.10.2017 12:15Pressemelding

Westinghouse Electric Company today announced that it has received approval from the U.S. Nuclear Regulatory Commission (NRC) for two new important analysis methodologies that will be used to upgrade Westinghouse- and Combustion Engineering-based nuclear steam supply system (NSSS) safety analyses. The approvals granted are for the new FULL SPECTRUMTM Loss of Coolant Accident (FSLOCATM) methodology and the Performance Analysis and Design Model software code update, PAD5. FSLOCA is capable of improved modeling of the transient response in a pressurized water reactor to the full spectrum of LOCA break sizes that could occur, and PAD5 is the next generation of the Westinghouse fuel rod design performance code. “These codes were developed to work in concert with each other to maximize analytical margin for nuclear utilities,” said Michele DeWitt, senior vice preside

Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®20.10.2017 12:03Pressemelding

Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from Phase 2 and Phase 3 studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection, adding to the body of evidence supporting Gilead’s viral hepatitis therapies in diverse patient populations. These and other data from more than 25 abstracts will be presented this week at The Liver Meeting® 2017, which begins today in Washington, D.C. Positive results from studies of Harvoni® (ledipasvir 90mg/sofosbuvir 400mg) in HCV-infected patients with severe renal impairment, Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) in HCV-infected liver transplant recipients and Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg) in NS5A-inhibitor experienced HCV-infected patients will be presented during poster sessions on October 21 and October 22. In addition, updated results f

SP3H Announces That It Has Obtained a €1.2 Million European Union Grant for Its Intelligent and Clean Vehicle (VIP) Project20.10.2017 10:47Pressemelding

SP3H is proud to announce joining the very select circle of the 10 French winners of the H2020 SME Instrument Phase 2 program since 2014. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171020005325/en/ Last summer VIP received the very prestigious SME instrument phase 2 H2020 label in the "transport & smart cities mobility" category. With an overall budget of € 1.7 million, VIP is subsidized by the European Union at a rate of 70% or €1.2 million. The framework contract was officially signed early October. VIP is the pre-industrialization program for Fuelbox sensors, the world's first miniaturized scanner capable of analyzing the quality of fuels on board vehicles. The heart of the program remains closely linked to the reduction of CO2 and pollutant emissions from vehicle

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom